Recently Diagnosed or Relapsed? Stop Looking For a Miracle Cure, and Use Evidence-Based Therapies To Enhance Your Treatment and Prolong Your Remission
Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
- You are here:
- Home »
- Blog »
- Multiple Myeloma »
- Heart Health in Myeloma Survivors
Heart Health in Myeloma Survivors
Heart health in Myeloma Survivors is at increased risk according to the studies linked below. To be clear, the studies focus on all cancer patients. Being a MM survivor myself, I chose to focus on MM patients exclusively.
I think it is fair to focus solely on MM survivors because the average age of NDMM patients is 70 and many of the chemo regimens used in MM treatment are cardiotoxic. Think
- Melphalan
- Cytoxan
- Velcade
- Revlimid
Study Finds Cancer Patients Face Twice the Heart Disease Risk
I developed chronic atrial fibrillation in December of 2010 almost 15 years to the day following my ASCT. I was diagnosed with chemotherapy-induced cardiomyopathy (CIC) shortly thereafter.
Heart damage from chemotherapy can develop immediately during administration or it can take years before making itself known to the MM survivor.
I have been studying CIC since my diagnosis in 2010. Cardiotoxicity has slowly become a bigger and bigger issue in that time. We’ve gotten to the point where the American Cancer Society is going on record as saying that ALL cancer survivors are at risk of chemotherapy-induced cardiomyopathy.
The solution in my experience is for MM patients to live a heart healthy lifestyle regardless of whether or not you’ve been diagnosed with CIC. The last article linked below talks about “modifiable risk factors” to improve heart health.
A heart healthy modifiable risk factor that I included in my heart health regime has been to include heart healthy nutritional supplements such as:
- CoQ10
- Curcumin
- Omega-3 fatty acids
- Taurine
- D-Ribose
- Cocoa Powder
and others, to my daily routine.
David Emerson
- MM Survivor
- MM Cancer Coach
- Director PeopleBeatingCancer
Cardiovascular disease and stroke following cancer and cancer treatment in older adults
“Background
Cancer survivors can be at risk of cardiovascular disease (CVD) because of either their malignancy or its treatment. Although studies linking cancer and CVD exist, few examine risk in older adults, the impact of cancer treatment, or the effect of aspirin on reducing risk in this cohort.
Methods
The authors conducted a secondary analysis of the Aspirin in Reducing Events in the Elderly (ASPREE) trial to investigate the impact of cancer and cancer treatment on a composite CVD end point comprising hospitalization for heart failure (HHF), myocardial infarction (MI), and stroke.
Results
Of 15,454 Australian and US ASPREE participants, 1392 had an incident cancer diagnosis. Rates of CVD were greater in the cancer risk-set compared to the cancer-free risk-set (20.8 vs. 10.3 events per 1000 person-years; incidence rate ratio, 2.03; 95% confidence interval, 1.51–2.66), with increased incidence seen across MI, HHF, overall stroke, and ischemic stroke. Increased incidence remained after adjustment for clinically significant risk factors for CVD. Incidence was greatest in metastatic, hematological, and lung cancer.
Chemotherapy was associated with increased risk of CVD. Similar rates of CVD were seen across aspirin and placebo groups.
Conclusions
Incidence of CVD, including MI, HHF, and ischemic stroke, was increased in older adults with cancer. Aspirin did not impact CVD incidence. Risk may be higher in those with metastatic, hematological, and lung cancer, and following chemotherapy…”
Investigating modifiable risk factors associated with ideal cardiovascular health among cancer survivors: a scoping review
“Background
Cancer survivors are at higher risk of developing cardiovascular diseases and face worse morbidity and mortality outcomes than the general population. The American Heart Association (AHA) introduced the Life’s Essential 8 framework, encompassing eight modifiable risk factors and lifestyle behaviors for maintaining ideal cardiovascular health (CVH).
Although this framework is well-established for predicting CVH in the general population, studies on its association with cardiovascular outcomes among cancer survivors remain scattered across the literature.
Objective
This review maps existing literature surrounding modifiable risk factors, lifestyle behaviors, CVH, and cardiovascular outcomes among cancer survivors to take stock of what is known, identify methodological strengths and weaknesses, and propose promising research directions.
Methods
A scoping review was conducted to identify studies examining different dimensions of ideal CVH in adult cancer survivors. Measurement methods of ideal CVH metrics, and determinants associated with CVH were examined.
Results
Twenty-two articles met eligibility criteria. Of which, 82% (n = 18) were published in or after 2020. Fourteen studies (about 64%) followed the AHA’s framework to conceptualize ideal CVH.
Higher scores on ideal CVH are linked to better cardiovascular outcomes among cancer survivors with associations noted for social inequalities and neighborhood environmental factors, underscoring the complexity of CVH determinants in this population.
Conclusions
Research on ideal CVH among cancer survivors appears to have accelerated in recent years, yet many gaps remain to orient clinical and public health practice. Promising research directions include expanding investigations into pre-diagnosis CVH, addressing disparities in CVH across diverse populations, and conducting longitudinal studies to clarify causal pathways between lifestyle behaviors, cancer treatments, and cardiovascular outcomes.”
Heart health Myeloma Survivors Heart health Myeloma Survivors Heart health Myeloma Survivors